Publication | Closed Access

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

Lymphoid NeoplasiaPost-transplant Cytomegalovirus ComplicationsCell TherapyTransplantationLymphoma PatientsRituximab TherapyStem Cell TransplantationImmunologyImmunotherapyMedicineCell Transplantation